Skip to content

Study · Not a test of the peptide alone · 2003

2 results

[The use of antioxidants and antihypoxants for decreasing of LDL oxidation by macrophages and endothelial cells in ischemia and reperfusion of vascular wall].

Bilenko MV, Khil'chenko AV, Pavlova SA

Biomeditsinskaia khimiia1 Nov 2003

PMID16119084 (opens in a new tab)PepBankPUB-16119084

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study2

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone2

In this study, Delta sleep-inducing peptide (DSIP) was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Delta sleep-inducing peptide (DSIP).

  1. 01LabNot a test of Delta sleep-inducing peptide (DSIP) aloneIn vitro (cells)Activity measurement

    In macrophage and endothelial cell cultures, the antihypoxant preparation deltaran inhibited LDL oxidation more than succinic acid, and hypoxane had no effect.

    In plain wordsIn lab tests, the preparation deltaran reduced LDL oxidation more than succinic acid did. It is a combination product, not DSIP alone.

    Outcome
    DecreaseInhibition of macrophage- and endothelial cell-mediated LDL oxidation
    Study

    n: not reported in source

    macrophage and endothelial cell cultures
    Comparator
    Succinic acid and hypoxane
    Outcome group
    Inflammation markers · Cardiovascular

    Source sentences

    Summary
    antihypoxant ability was decreased in line: deltaran >> succinic acid (effect only in dose 40 mg/ml) >> hypoxane (no effect).
    1 context sentence
    Summary · context
    In this work the effects of antioxidants (K-phenosan, probucol, and desferal) and antihypoxants (succinic acid, hypoxen, and deltaran) on the macrophage- and endothelial cell-mediated oxidation of LDL was studied.

    In this study, Delta sleep-inducing peptide (DSIP) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Delta sleep-inducing peptide (DSIP).

  2. 02LabNot a test of Delta sleep-inducing peptide (DSIP) aloneIn vitro (cells)Activity measurement

    In macrophage cultures, deltaran protected macrophage viability less than succinic acid and hypoxen.

    In plain wordsIn lab tests, the preparation deltaran protected macrophage cells less than succinic acid or hypoxen did.

    Outcome
    Not applicableProtection of macrophage viability during ischemia
    Study

    n: not reported in source

    macrophage and endothelial cell cultures
    Comparator
    Succinic acid and hypoxen
    Outcome group
    Inflammation markers · Cardiovascular

    Source sentences

    Summary
    The effectiveness of antihypoxant protection of MP viability, decreased in the following order: succinic acid > hypoxen >> deltaran.
    1 context sentence
    Summary · context
    In this work the effects of antioxidants (K-phenosan, probucol, and desferal) and antihypoxants (succinic acid, hypoxen, and deltaran) on the macrophage- and endothelial cell-mediated oxidation of LDL was studied.

    In this study, Delta sleep-inducing peptide (DSIP) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Delta sleep-inducing peptide (DSIP).

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    12 Oct 2026, 17:28 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 12:40 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.